Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Gait Adaptation and Biofeedback for Cerebral Palsy

NCT: NCT05899153 · RECRUITING

NCT IDNCT05899153
StatusRECRUITING
Start Date2023-11-28
Completion2029-01-01
SponsorUniversity of Washington (OTHER)
First posted
Last updated

Brief Summary

This research aims to evaluate walking function in children with cerebral palsy (CP). The researchers want to understand how children with CP adapt and learn new ways of moving. They have previously found that measuring how a person controls their muscles is important for assessing walking ability and response to interventions. In these studies, they will adjust the treadmill belt speeds and/or provide real-time feedback to evaluate how a child can alter their movement. The feedback will include a wearable exoskeleton that provides resistance to the ankle and audio and visual cues based on sensors that record muscle activity. This research will investigate three goals: first, to measure how children with CP adapt their walking; second, to see if either repeated training or orthopedic surgery can improve adaptation rates; and third, to determine if individual differences in adaptation relate to improvements in walking function after treatment. This research will help develop better treatments to enhance walking capacity and performance for children with CP.

Frequently Asked Questions

What is Gait Adaptation and Biofeedback for Cerebral Palsy?

Gait Adaptation and Biofeedback for Cerebral Palsy is a clinical trial registered under NCT05899153. Current status: RECRUITING.

What is the status of NCT05899153?

The current status of NCT05899153 (Gait Adaptation and Biofeedback for Cerebral Palsy) is: RECRUITING.

When did Gait Adaptation and Biofeedback for Cerebral Palsy start?

Gait Adaptation and Biofeedback for Cerebral Palsy started on 2023-11-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.